Key stats
About ISHARES S&P GLB HE IDX CAD HED GLOBAL HEALTHCARE INDEX ETF HGD CAD
Expense ratio
0.66%
Home page
Inception date
Apr 12, 2011
The fund offers marketlike exposure to global pharmaceutical, biotechnology, and medical device companies. The underlying index is selected and weighted by float-adjusted market-cap. It pulls from the S&P Global 1200 universe, which effectively screens out small-caps, giving the fund a large-cap tilt. Aside from that, geographic and sector weights look neutral and make it a viable entry-point to global healthcare. The underlying index is hedged to Canadian dollars on a monthly basis. XHC will mainly invest in one or more iShares ETFs that reflects the underlying index exposure.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
ETF
Bonds, Cash & Other100.00%
ETF99.90%
Cash0.10%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history